Trial Profile
A phase I/II clinical trial to evaluate the safety and immunogenicity of LC16m8, a modified vaccinia vaccine, in healthy volunteers
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Pharmacodynamics
- Sponsors VaxGen
- 22 Oct 2005 New trial record.